Kalvista Pharmaceuticals Inc KALV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:39 AM EDT
12.87quote price arrow up+0.38 (+3.04%)
Volume
8,019
52 week range
7.21 - 16.88
Loading...
  • Open12.70
  • Day High12.92
  • Day Low12.69
  • Prev Close12.49
  • 52 Week High16.88
  • 52 Week High Date02/01/24
  • 52 Week Low7.21
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap542.963M
  • Shares Out42.19M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change1.96

KEY STATS

  • Open12.70
  • Day High12.92
  • Day Low12.69
  • Prev Close12.49
  • 52 Week High16.88
  • 52 Week High Date02/01/24
  • 52 Week Low7.21
  • 52 Week Low Date11/13/23
  • Market Cap542.963M
  • Shares Out42.19M
  • 10 Day Average Volume0.25M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change1.96

RATIOS/PROFITABILITY

  • EPS (TTM)-3.14
  • P/E (TTM)-4.10
  • Fwd P/E (NTM)-4.69
  • EBITDA (TTM)-122.933M
  • ROE (TTM)-79.33%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-990.38%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kalvista Pharmaceuticals Inc

 

Profile

MORE
KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting the disease hereditary angioedema (HAE). The Company is developing sebetralstat as an oral on-demand therapy for HAE attacks and has achieved target enrollment for the...
Brian Pereira M.D.
Independent Non-Executive Chairman of the Board
Benjamin Palleiko
Chief Executive Officer, Director
Address
55 Cambridge Pkwy Ste 901E
Cambridge, MA
02142-1234
United States

Top Peers

SYMBOLLASTCHG%CHG
CELC
Celcuity Inc
17.01+0.12+0.71%
ALT
Altimmune Inc
8.22+0.40+5.12%
APLT
Applied Therapeutics Inc
4.91+0.27+5.82%
OLMA
Olema Pharmaceuticals Inc
10.49+0.32+3.15%
CABA
Cabaletta Bio Inc
12.29+1.06+9.44%